Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth R Bauer

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Hospital Pharmacy|December 26, 2017
AKD-The Time Between AKI and CKD: What Is the Role of the Pharmacist?Sandra L Kane-Gill, Seth R Bauer
Hospital Pharmacy|August 26, 2016
Outcome Assessment of Critical Care Pharmacist ServicesSeth R Bauer, Sandra L Kane-Gill
Critical Care Medicine|September 15, 2022
The authors replyGretchen L Sacha, Lu Wang, Seth R Bauer
Pharmacotherapy|January 16, 2019
Vasoactive Agent Use in Septic Shock: Beyond First-Line RecommendationsGretchen L Sacha, Seth R Bauer, Ishaq Lat
American Journal of Therapeutics|October 6, 2020
Feasibility of Converting Inhaled Epoprostenol Product From Flolan to Veletri in Critically Ill PatientsHeather Torbic, Seth R Bauer, Matthew R Wanek
International Journal of Antimicrobial Agents|December 15, 2015
Procalcitonin-based algorithms to initiate or stop antibiotic therapy in critically ill patients: Is it time to rethink our strategy?Simon W Lam, Seth R Bauer, Abhijit Duggal
Journal of Pharmacy Practice|June 30, 2011
Toxicology today: what you need to know nowSimon W Lam, Kristin M Engebretsen, Seth R Bauer
Critical Care Medicine|August 19, 2009
Corticosteroids in acute lung injury and acute respiratory distress syndromeSeth R Bauer, Simon W Lam, Gustavo A Heresi
Cleveland Clinic Journal of Medicine|March 5, 2013
Septic shock: the initial moments and beyondSimon W Lam, Seth R Bauer, Jorge A Guzman
Pharmacotherapy|January 6, 2023
Precision fluid and vasoactive drug therapy for critically ill patientsSeth R Bauer, Rochelle M Gellatly, Brian L Erstad
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Hospital Pharmacy|December 26, 2017
AKD-The Time Between AKI and CKD: What Is the Role of the Pharmacist?Sandra L Kane-Gill, Seth R Bauer
Hospital Pharmacy|August 26, 2016
Outcome Assessment of Critical Care Pharmacist ServicesSeth R Bauer, Sandra L Kane-Gill
Critical Care Medicine|September 15, 2022
The authors replyGretchen L Sacha, Lu Wang, Seth R Bauer
Pharmacotherapy|January 16, 2019
Vasoactive Agent Use in Septic Shock: Beyond First-Line RecommendationsGretchen L Sacha, Seth R Bauer, Ishaq Lat
American Journal of Therapeutics|October 6, 2020
Feasibility of Converting Inhaled Epoprostenol Product From Flolan to Veletri in Critically Ill PatientsHeather Torbic, Seth R Bauer, Matthew R Wanek
International Journal of Antimicrobial Agents|December 15, 2015
Procalcitonin-based algorithms to initiate or stop antibiotic therapy in critically ill patients: Is it time to rethink our strategy?Simon W Lam, Seth R Bauer, Abhijit Duggal
Journal of Pharmacy Practice|June 30, 2011
Toxicology today: what you need to know nowSimon W Lam, Kristin M Engebretsen, Seth R Bauer
Critical Care Medicine|August 19, 2009
Corticosteroids in acute lung injury and acute respiratory distress syndromeSeth R Bauer, Simon W Lam, Gustavo A Heresi
Cleveland Clinic Journal of Medicine|March 5, 2013
Septic shock: the initial moments and beyondSimon W Lam, Seth R Bauer, Jorge A Guzman
Pharmacotherapy|January 6, 2023
Precision fluid and vasoactive drug therapy for critically ill patientsSeth R Bauer, Rochelle M Gellatly, Brian L Erstad
Pageof 12